Skip to main content
. 2017 Jul 24;7:6238. doi: 10.1038/s41598-017-06217-9

Figure 5.

Figure 5

Different treatment effects of HLJDT-M (a) and HLJDT (a) on the levels of APP metabolites, phospho-Tau and total Tau in 3XTg-AD mice. Immunoblot presenting the levels of FL-APP, CTFs (CTFα and CTFβ), pAPP and pCTFs (α and β). Quantification of immunoblots by densitometric analysis and is presented as the ratio of FL-APP, CTFs, pAPP, PHF-1 Tau, total Tau and pCTFs against β-actin in the SDS brain lysates of 3XTgAD mice treated with HLJDT-M or HLJDT or vehicle (c and d). The statistical significance are denoted as *p < 0.05, **p < 0.01, **p < 0.001 when compared with vehicle-treated 3XTg-AD mice. Data represent mean ± SEM. N = 8 mice per group.